Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Details Narrative)

v3.20.2
Stockholders' Equity (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended
Aug. 13, 2020
Jul. 23, 2020
May 05, 2020
Dec. 27, 2019
Nov. 15, 2019
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Dec. 31, 2019
Offering Costs               $ 963,754 $ 3,636  
Net Proceeds               $ 29,756,736 83,453  
Common stock, par value           $ 0.0001   $ 0.0001   $ 0.0001
Common stock, issued during the period, value       $ 474,808   $ 21,985,976 $ 79,817 $ 28,792,982 $ 79,817  
Common stock issued during period         1,058,558          
Preferred stock, shares outstanding              
Number of existing stock options               1,587,500    
New Restricted Stock Units [Member]                    
Stock option granted     1,587,500              
Restricted stock option price     $ 0.43              
Number of options term     1 year              
Series B Convertible Preferred Stock [Member]                    
Preferred stock, shares outstanding                
Series E Convertible Preferred Stock [Member]                    
Preferred stock, shares outstanding                
Directors and Officers [Member] | Restricted Stock Units [Member]                    
Stock option granted     1,158,138              
Restricted stock option price     $ 0.43              
Number of options term     1 year              
Merrick Okamoto [Member]                    
Cash award     $ 105,000              
David Lieberman [Member]                    
Cash award     $ 54,000              
Underwriting Agreement [Member] | Underwriter [Member]                    
Sale of stock   7,666,666                
Stock option granted   999,999                
Shares issued price   $ 0.90                
Gross Proceeds   $ 6,900,000                
Offering Costs   600,000                
Net Proceeds   $ 6,300,000                
Warrant to purchase common stock   536,667                
Warrant term   5 years                
Warrant excerise price   $ 1.125                
2020 At the Market Agreement [Member]                    
Offering Costs               $ 1,000,000    
Net Proceeds               $ 28,800,000    
Common stock, par value $ 0.0001                  
Common stock issued during period               17,712,635    
2020 At the Market Agreement [Member] | Maximum [Member]                    
Common stock, issued during the period, value $ 100,000,000